Blinatumomab (active substance) - analogs
Pharmgroups: Antitumor agents - monoclonal antibodies |
|||||||||
| Prices in pharmacies: Instructions Blinatumomab | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Blinatumomab included in the composition |
Prices in pharmacies |
| Blincyto | 1913.5€ |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 42% Inotuzumab ozogamicin
- 39% Obinutuzumab
- 39% Ofatumumab
- 31% Dasatinib
- 31% Bosutinib
- 29% Amsacrine
- 28% Imatinib
- 28% Nelarabine
- 28% Tioguanine
- 24% Molgramostim
- 23% Mercaptopurine
- 23% Pegaspargase
- 22% Pertuzumab
- 22% Catumaxomab
- 22% Elotuzumab
- 20% Hexaphosphamide
- 20% Nilotinib
- 20% Durvalumab
- 20% Isatuximab
- 20% Ipilimumab
- 20% Venetoclax
- 19% Trastuzumab
- 19% Akalabrutinib
- 18% Idarubicin
- 17% Trastuzumab emtansine
- 17% Cetuximab
- 17% Avelumab
- 17% Prolgolimab
- 16% Asparaginase
- 16% Bevacizumab
- 16% Cytarabine
- 15% Daratumumab
- 15% Fludarabine
- 15% Prodimin
- 15% Paphencyl
- 14% Pembrolizumab
- 14% Nivolumab
- 14% Dipin
- 14% Chlorethylaminouracil
- 13% Ibrutinib
- 12% Lenograstim
- 12% Midostaurin
- 11% Lophenalac
- 10% Ceritinib
- 10% Atezolizumab
- 10% Panobinostat
- 10% Enzalutamide
- 10% Ribociklib
- 10% Gefitinib
- 10% Mitotane
Learn more about the selection of analogues
- The drug has «Blinatumomab» 51 analog by action, the most similar - Inotuzumab ozogamicin .
- Medical online service has selected the best substitutes for Blinatumomab based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Blinatumomab to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.